Kestra Private Wealth Services’s Rani Therapeutics RANI Stock Holding History

Kestra Private Wealth Services’s Portfolio RANI Stock Details RANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$230K	Buy	290,376 +8,036	+3%	+$6.41K	﹤0.01%	1618
2026 Q2	$215K	Buy	282,340 +17,181	+6%	+$15.2K	﹤0.01%	1666
2026 Q1	$195K	Buy	265,159 +10,347	+4%	+$13.2K	﹤0.01%	1646
2025 Q4	$344K	Buy	254,812 +28,670	+13%	+$43.3K	﹤0.01%	1359
2025 Q3	$113K	Buy	226,142 +70,002	+45%	+$36.5K	﹤0.01%	1601
2025 Q2	$80.2K	Buy	156,140 +16,984	+12%	+$13.9K	﹤0.01%	1561
2025 Q1	$175K	Buy	139,156 +19,536	+16%	+$28.9K	﹤0.01%	1405
2024 Q4	$164K	Buy	+119,620	New	+$251K	﹤0.01%	1334

Other funds holding RANI

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Well Done LLC Holland, Michigan $732M AUM 14.62% 1-Year Est. Return

Traphagen Investment Advisors Oradell, New Jersey $1.46B AUM 14.92% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

ACT Advisors Asheville, North Carolina $308M AUM 16.31% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Glass Jacobson Investment Advisors Owings Mills, Maryland $326M AUM 13.52% 1-Year Est. Return

Kestra Private Wealth Services's RANI Position: Q3 2026 in Review

Kestra Private Wealth Services increased its Rani Therapeutics (RANI) stake by 2.8% in Q3 2026, buying an estimated $6.41K and bringing the position to 290,376 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

Kestra Private Wealth Services first reported a position in RANI in Q4 2024 and has held it in 8 quarters since. The position peaked at $344K in Q4 2025. 12 funds tracked by Wall St. Rank hold RANI as of Q3 2026.

Kestra Private Wealth Services held 290,376 shares of Rani Therapeutics worth $230K as of Q3 2026.
Kestra Private Wealth Services bought 8,036 Rani Therapeutics shares in Q3 2026, an estimated $6.41K.
Rani Therapeutics made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q3 2026, its #1618 holding.
Kestra Private Wealth Services first reported a position in Rani Therapeutics in Q4 2024 and has held it in 8 quarters since.
Kestra Private Wealth Services's Rani Therapeutics position peaked at $344K in Q4 2025.
12 funds tracked by Wall St. Rank held Rani Therapeutics as of Q3 2026.

Based on Kestra Private Wealth Services's 13F filing for Q3 2026, filed 30 Oct 2026.